Results 191 to 200 of about 6,539 (200)

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Respiratory Medicine,the, 2017
Eugene R Bleecker
exaly  

Benralizumab/budesonide/formoterol

Reactions Weekly, 2022
openaire   +1 more source

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

New England Journal of Medicine
Evan Dellon, Albert J Bredenoord, Ikuo Hirano   +2 more
exaly  

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

New England Journal of Medicine
Benjamin Terrier, Arnaud Bourdin, David R Jayne   +2 more
exaly  

Benralizumab

Österreichische Apothekerzeitung, 2017
openaire   +1 more source

Benralizumab/dupilumab

Reactions Weekly
openaire   +2 more sources

Benralizumab/mepolizumab/omalizumab

Reactions Weekly, 2020
openaire   +1 more source

Reductions in eosinophil biomarkers by benralizumab in patients with asthma

Respiratory Medicine, 2016
exaly  

Benralizumab/corticosteroids/mepolizumab

Reactions Weekly
openaire   +1 more source

Benralizumab/Mepolizumab/Omalizumab

Reactions Weekly
openaire   +1 more source